These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 23313277

  • 1. Salivary cortisol levels and the 2-year course of depressive and anxiety disorders.
    Vreeburg SA, Hoogendijk WJ, DeRijk RH, van Dyck R, Smit JH, Zitman FG, Penninx BW.
    Psychoneuroendocrinology; 2013 Sep; 38(9):1494-502. PubMed ID: 23313277
    [Abstract] [Full Text] [Related]

  • 2. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW.
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [Abstract] [Full Text] [Related]

  • 3. Salivary cortisol levels in persons with and without different anxiety disorders.
    Vreeburg SA, Zitman FG, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Hoogendijk WJ, Smit JH, Penninx BW.
    Psychosom Med; 2010 May; 72(4):340-7. PubMed ID: 20190128
    [Abstract] [Full Text] [Related]

  • 4. Parental history of depression or anxiety and the cortisol awakening response.
    Vreeburg SA, Hartman CA, Hoogendijk WJ, van Dyck R, Zitman FG, Ormel J, Penninx BW.
    Br J Psychiatry; 2010 Sep; 197(3):180-5. PubMed ID: 20807961
    [Abstract] [Full Text] [Related]

  • 5. Increased cortisol awakening response was associated with time to recurrence of major depressive disorder.
    Hardeveld F, Spijker J, Vreeburg SA, Graaf RD, Hendriks SM, Licht CM, Nolen WA, Penninx BW, Beekman AT.
    Psychoneuroendocrinology; 2014 Dec; 50():62-71. PubMed ID: 25179322
    [Abstract] [Full Text] [Related]

  • 6. Antidepressant use and salivary cortisol in depressive and anxiety disorders.
    Manthey L, Leeds C, Giltay EJ, van Veen T, Vreeburg SA, Penninx BW, Zitman FG.
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):691-9. PubMed ID: 21458959
    [Abstract] [Full Text] [Related]

  • 7. Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers.
    Vogel SWN, Bijlenga D, Verduijn J, Bron TI, Beekman ATF, Kooij JJS, Penninx BWJH.
    Psychoneuroendocrinology; 2017 May; 79():31-39. PubMed ID: 28249186
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic-pituitary-adrenal axis activity in older persons with and without a depressive disorder.
    Rhebergen D, Korten NC, Penninx BW, Stek ML, van der Mast RC, Oude Voshaar R, Comijs HC.
    Psychoneuroendocrinology; 2015 Jan; 51():341-50. PubMed ID: 25462906
    [Abstract] [Full Text] [Related]

  • 9. The relationships of working conditions, recent stressors and childhood trauma with salivary cortisol levels.
    Holleman M, Vreeburg SA, Dekker JJ, Penninx BW.
    Psychoneuroendocrinology; 2012 Jun; 37(6):801-9. PubMed ID: 22000684
    [Abstract] [Full Text] [Related]

  • 10. The predictive value of cortisol levels on 2-year course of depression in older persons.
    Kabia FM, Rhebergen D, van Exel E, Stek ML, Comijs HC.
    Psychoneuroendocrinology; 2016 Jan; 63():320-6. PubMed ID: 26546785
    [Abstract] [Full Text] [Related]

  • 11. Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders.
    Veen G, Giltay EJ, DeRijk RH, van Vliet IM, van Pelt J, Zitman FG.
    Metabolism; 2009 Jun; 58(6):821-7. PubMed ID: 19375126
    [Abstract] [Full Text] [Related]

  • 12. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW, Quitkin FM, McGrath PJ, Klein DF.
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [Abstract] [Full Text] [Related]

  • 13. Reduced hypothalamic-pituitary-adrenal axis activity in chronic multi-site musculoskeletal pain: partly masked by depressive and anxiety disorders.
    Generaal E, Vogelzangs N, Macfarlane GJ, Geenen R, Smit JH, Penninx BW, Dekker J.
    BMC Musculoskelet Disord; 2014 Jul 09; 15():227. PubMed ID: 25007969
    [Abstract] [Full Text] [Related]

  • 14. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis.
    Wardenaar KJ, Vreeburg SA, van Veen T, Giltay EJ, Veen G, Penninx BW, Zitman FG.
    Biol Psychiatry; 2011 Feb 15; 69(4):366-73. PubMed ID: 21030010
    [Abstract] [Full Text] [Related]

  • 15. Prospective associations between the cortisol awakening response and first onsets of anxiety disorders over a six-year follow-up--2013 Curt Richter Award Winner.
    Adam EK, Vrshek-Schallhorn S, Kendall AD, Mineka S, Zinbarg RE, Craske MG.
    Psychoneuroendocrinology; 2014 Jun 15; 44():47-59. PubMed ID: 24767619
    [Abstract] [Full Text] [Related]

  • 16. Altered psychobiological responsiveness in women with irritable bowel syndrome.
    Suárez-Hitz KA, Otto B, Bidlingmaier M, Schwizer W, Fried M, Ehlert U.
    Psychosom Med; 2012 Jun 15; 74(2):221-31. PubMed ID: 22286854
    [Abstract] [Full Text] [Related]

  • 17. Are flatter diurnal cortisol rhythms associated with major depression and anxiety disorders in late adolescence? The role of life stress and daily negative emotion.
    Doane LD, Mineka S, Zinbarg RE, Craske M, Griffith JW, Adam EK.
    Dev Psychopathol; 2013 Aug 15; 25(3):629-42. PubMed ID: 23880381
    [Abstract] [Full Text] [Related]

  • 18. Co-occurring manic symptomatology influences HPA axis alterations in depression.
    Jabben N, Nolen WA, Smit JH, Vreeburg SA, Beekman AT, Penninx BW.
    J Psychiatr Res; 2011 Sep 15; 45(9):1208-13. PubMed ID: 21450306
    [Abstract] [Full Text] [Related]

  • 19. Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system.
    Boschloo L, Vogelzangs N, Licht CM, Vreeburg SA, Smit JH, van den Brink W, Veltman DJ, de Geus EJ, Beekman AT, Penninx BW.
    Drug Alcohol Depend; 2011 Jul 01; 116(1-3):170-6. PubMed ID: 21330066
    [Abstract] [Full Text] [Related]

  • 20. Hypothalamic-pituitary-adrenal axis activity in the comorbidity between obsessive-compulsive disorder and major depression.
    Labad J, Soria V, Salvat-Pujol N, Segalàs C, Real E, Urretavizcaya M, de Arriba-Arnau A, Ferrer A, Crespo JM, Jiménez-Murcia S, Soriano-Mas C, Alonso P, Menchón JM.
    Psychoneuroendocrinology; 2018 Jul 01; 93():20-28. PubMed ID: 29684711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.